Euroapi

Highly Engaged Employees

Euroapi, established in 2021, is a prominent pharmaceutical manufacturer specializing in active pharmaceutical ingredients (APIs). The company boasts a portfolio of approximately 200 products and offers Contract Development and Manufacturing Organization (CDMO) services, supporting innovative molecule development. Its core mission involves creating sustainable active ingredient solutions for global healthcare partners, leveraging scientific excellence and industrial expertise to meet stringent quality standards. Euroapi operates within the Pharmaceutical and Healthcare sectors, providing essential components for drug production.

With a significant operational footprint, Euroapi manages six manufacturing sites strategically located across Europe, including facilities in France, Italy, Germany, Hungary, and the United Kingdom. This extensive network supports its role as a key supplier to customers in over 80 countries worldwide. The company employs between 1,000 - 5,000 individuals, reflecting its substantial scale and operational capacity. For insights into the people driving this enterprise, you can Meet Euroapi's team. This infrastructure underpins its commitment to reliable, high-quality pharmaceutical production and development.

Euroapi is publicly traded on Euronext Paris, underscoring its market presence and financial transparency. The company generated revenue of $1.0B, demonstrating substantial commercial activity. Further details on its financial performance and investment activities are available via Explore financial highlights. Its strategic focus on API manufacturing and CDMO services positions it as a critical partner in the global pharmaceutical supply chain, contributing to patient health through advanced ingredient solutions.